Back

Genprex to present Reqorsa gene therapy at H.C. Wainwright conference

Verifying
  • Genprex will present Reqorsa and its preclinical diabetes program at an investment conference.
  • September 14, 2026, is the scheduled presentation date in New York City.
  • Reqorsa is Genprex’s lead oncology gene therapy program.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.